Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer

NCT02418312 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Peptic Ulcer

Interventions

DRUG: histamine-2 receptor antagonist
DRUG: Placebo

Sponsor

Kaohsiung Veterans General Hospital.